Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model

Gregory O'Connor, Elisabeth Jeffrey, Derik Madorma, Alexander Marcillo, Maria T Abreu, Sapna K Deo, W. Dalton Dietrich, Sylvia Daunert

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Although there has been a significant amount of research focused on the pathophysiology of spinal cord injury (SCI), there is limited information on the consequences of SCI on remote organs. SCI can produce significant effects on a variety of organ systems, including the gastrointestinal tract. Patients with SCI often suffer from severe, debilitating bowel dysfunction in addition to their physical disabilities, which is of major concern for these individuals because of the adverse impact on their quality of life. Herein, we report on our investigation into the effects of SCI and subsequent antibiotic treatment on the intestinal tissue and microbiota. For that, we used a thoracic SCI rat model and investigated changes to the microbiota, proinflammatory cytokine levels, and bacterial communication molecule levels post-injury and gentamicin treatment for 7 days. We discovered significant changes, the most interesting being the differences in the gut microbiota beta diversity of 8-week SCI animals compared to control animals at the family, genus, and species level. Specifically, 35 operational taxonomic units were enriched in the SCI animal group and three were identified at species level; Lactobacillus intestinalis, Clostridium disporicum, and Bifidobacterium choerinum. In contrast, Clostridium saccharogumia was identified as depleted in the SCI animal group. Proinflammatory cytokines interleukin (IL)-12, macrophage inflammatory protein-2 (MIP-2), and tumor necrosis factor alpha were found to be significantly elevated in intestinal tissue homogenate 4 weeks post-SCI compared to 8-weeks post-injury. Further, levels of IL-1β, IL-12, and MIP-2 significantly correlated with changes in beta diversity 8-weeks post-SCI. Our data provide a greater understanding of the early effects of SCI on the microbiota and gastrointestinal tract, highlighting the need for further investigation to elucidate the mechanism underlying these effects.

Original languageEnglish (US)
Pages (from-to)2159-2166
Number of pages8
JournalJournal of Neurotrauma
Volume35
Issue number18
DOIs
StatePublished - Sep 15 2018

Fingerprint

Spinal Cord Injuries
Inflammation
Chemokine CXCL2
Clostridium
Microbiota
Interleukin-12
Gastrointestinal Tract
Gastrointestinal Microbiome
Cytokines
Thoracic Injuries
Bifidobacterium
Wounds and Injuries
Lactobacillus
Gentamicins
Interleukin-1
Tumor Necrosis Factor-alpha
Communication
Quality of Life
Anti-Bacterial Agents

Keywords

  • Bifidobacterium choerinum
  • Clostridium disporicum
  • Clostridium saccharogumia
  • intestinal microbiome
  • Lactobacillus intestinalis
  • quorum sensing molecules
  • spinal cord injury

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model. / O'Connor, Gregory; Jeffrey, Elisabeth; Madorma, Derik; Marcillo, Alexander; Abreu, Maria T; Deo, Sapna K; Dalton Dietrich, W.; Daunert, Sylvia.

In: Journal of Neurotrauma, Vol. 35, No. 18, 15.09.2018, p. 2159-2166.

Research output: Contribution to journalArticle

@article{9b9078214e0648608b4c063d75dd8df2,
title = "Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model",
abstract = "Although there has been a significant amount of research focused on the pathophysiology of spinal cord injury (SCI), there is limited information on the consequences of SCI on remote organs. SCI can produce significant effects on a variety of organ systems, including the gastrointestinal tract. Patients with SCI often suffer from severe, debilitating bowel dysfunction in addition to their physical disabilities, which is of major concern for these individuals because of the adverse impact on their quality of life. Herein, we report on our investigation into the effects of SCI and subsequent antibiotic treatment on the intestinal tissue and microbiota. For that, we used a thoracic SCI rat model and investigated changes to the microbiota, proinflammatory cytokine levels, and bacterial communication molecule levels post-injury and gentamicin treatment for 7 days. We discovered significant changes, the most interesting being the differences in the gut microbiota beta diversity of 8-week SCI animals compared to control animals at the family, genus, and species level. Specifically, 35 operational taxonomic units were enriched in the SCI animal group and three were identified at species level; Lactobacillus intestinalis, Clostridium disporicum, and Bifidobacterium choerinum. In contrast, Clostridium saccharogumia was identified as depleted in the SCI animal group. Proinflammatory cytokines interleukin (IL)-12, macrophage inflammatory protein-2 (MIP-2), and tumor necrosis factor alpha were found to be significantly elevated in intestinal tissue homogenate 4 weeks post-SCI compared to 8-weeks post-injury. Further, levels of IL-1β, IL-12, and MIP-2 significantly correlated with changes in beta diversity 8-weeks post-SCI. Our data provide a greater understanding of the early effects of SCI on the microbiota and gastrointestinal tract, highlighting the need for further investigation to elucidate the mechanism underlying these effects.",
keywords = "Bifidobacterium choerinum, Clostridium disporicum, Clostridium saccharogumia, intestinal microbiome, Lactobacillus intestinalis, quorum sensing molecules, spinal cord injury",
author = "Gregory O'Connor and Elisabeth Jeffrey and Derik Madorma and Alexander Marcillo and Abreu, {Maria T} and Deo, {Sapna K} and {Dalton Dietrich}, W. and Sylvia Daunert",
year = "2018",
month = "9",
day = "15",
doi = "10.1089/neu.2017.5349",
language = "English (US)",
volume = "35",
pages = "2159--2166",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "18",

}

TY - JOUR

T1 - Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model

AU - O'Connor, Gregory

AU - Jeffrey, Elisabeth

AU - Madorma, Derik

AU - Marcillo, Alexander

AU - Abreu, Maria T

AU - Deo, Sapna K

AU - Dalton Dietrich, W.

AU - Daunert, Sylvia

PY - 2018/9/15

Y1 - 2018/9/15

N2 - Although there has been a significant amount of research focused on the pathophysiology of spinal cord injury (SCI), there is limited information on the consequences of SCI on remote organs. SCI can produce significant effects on a variety of organ systems, including the gastrointestinal tract. Patients with SCI often suffer from severe, debilitating bowel dysfunction in addition to their physical disabilities, which is of major concern for these individuals because of the adverse impact on their quality of life. Herein, we report on our investigation into the effects of SCI and subsequent antibiotic treatment on the intestinal tissue and microbiota. For that, we used a thoracic SCI rat model and investigated changes to the microbiota, proinflammatory cytokine levels, and bacterial communication molecule levels post-injury and gentamicin treatment for 7 days. We discovered significant changes, the most interesting being the differences in the gut microbiota beta diversity of 8-week SCI animals compared to control animals at the family, genus, and species level. Specifically, 35 operational taxonomic units were enriched in the SCI animal group and three were identified at species level; Lactobacillus intestinalis, Clostridium disporicum, and Bifidobacterium choerinum. In contrast, Clostridium saccharogumia was identified as depleted in the SCI animal group. Proinflammatory cytokines interleukin (IL)-12, macrophage inflammatory protein-2 (MIP-2), and tumor necrosis factor alpha were found to be significantly elevated in intestinal tissue homogenate 4 weeks post-SCI compared to 8-weeks post-injury. Further, levels of IL-1β, IL-12, and MIP-2 significantly correlated with changes in beta diversity 8-weeks post-SCI. Our data provide a greater understanding of the early effects of SCI on the microbiota and gastrointestinal tract, highlighting the need for further investigation to elucidate the mechanism underlying these effects.

AB - Although there has been a significant amount of research focused on the pathophysiology of spinal cord injury (SCI), there is limited information on the consequences of SCI on remote organs. SCI can produce significant effects on a variety of organ systems, including the gastrointestinal tract. Patients with SCI often suffer from severe, debilitating bowel dysfunction in addition to their physical disabilities, which is of major concern for these individuals because of the adverse impact on their quality of life. Herein, we report on our investigation into the effects of SCI and subsequent antibiotic treatment on the intestinal tissue and microbiota. For that, we used a thoracic SCI rat model and investigated changes to the microbiota, proinflammatory cytokine levels, and bacterial communication molecule levels post-injury and gentamicin treatment for 7 days. We discovered significant changes, the most interesting being the differences in the gut microbiota beta diversity of 8-week SCI animals compared to control animals at the family, genus, and species level. Specifically, 35 operational taxonomic units were enriched in the SCI animal group and three were identified at species level; Lactobacillus intestinalis, Clostridium disporicum, and Bifidobacterium choerinum. In contrast, Clostridium saccharogumia was identified as depleted in the SCI animal group. Proinflammatory cytokines interleukin (IL)-12, macrophage inflammatory protein-2 (MIP-2), and tumor necrosis factor alpha were found to be significantly elevated in intestinal tissue homogenate 4 weeks post-SCI compared to 8-weeks post-injury. Further, levels of IL-1β, IL-12, and MIP-2 significantly correlated with changes in beta diversity 8-weeks post-SCI. Our data provide a greater understanding of the early effects of SCI on the microbiota and gastrointestinal tract, highlighting the need for further investigation to elucidate the mechanism underlying these effects.

KW - Bifidobacterium choerinum

KW - Clostridium disporicum

KW - Clostridium saccharogumia

KW - intestinal microbiome

KW - Lactobacillus intestinalis

KW - quorum sensing molecules

KW - spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=85052903024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052903024&partnerID=8YFLogxK

U2 - 10.1089/neu.2017.5349

DO - 10.1089/neu.2017.5349

M3 - Article

VL - 35

SP - 2159

EP - 2166

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 18

ER -